GoodRx Holdings (GDRX) EPS (Weighted Average and Diluted) (2019 - 2026)
GoodRx Holdings recorded quarterly EPS (Weighted Average and Diluted) of $0.0 in Q1 2026, down 82.88% quarter-over-quarter from $0.02 in Q4 2025, and down 88.59% year-over-year from $0.03 in Q1 2025.
GoodRx Holdings' EPS (Weighted Average and Diluted) history runs 8 years deep, the most recent figure standing at $0.0 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 88.59% year-over-year to $0.0; the TTM figure through Mar 2026 stood at $0.06 (down 25.0% YoY), while the FY2025 annual figure was $0.09, up 125.0% from the prior year.
- EPS (Weighted Average and Diluted) came in at $0.0 for Q1 2026 at GoodRx Holdings, down from $0.02 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.14 in Q2 2023 to a low of -$0.1 in Q3 2022.
- A 5-year average of $0.0 and a median of $0.0 in 2026 frame the typical range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 4285.92% in 2023 and fell as far as 500.0% in 2023.
- GoodRx Holdings' EPS (Weighted Average and Diluted) stood at -$0.01 in 2022, then tumbled by 500.0% to -$0.06 in 2023, then surged by 133.33% to $0.02 in 2024, then dropped by 0.0% to $0.02 in 2025, then slumped by 82.88% to $0.0 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered $0.0, $0.02, and $0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 1.48 |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 0.67 |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 0.82 |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 0.41 |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 0.10 |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 0.22 |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -0.10 |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 0.02 |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 0.25 |
| 10 | GoodRx Holdings | 1.05 Bn | 814.83 Mn | 112.95 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | -0.09 |
| Jun 30, 2023 | 0.14 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | -0.01 |
| Sep 30, 2022 | -0.10 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | -0.09 |
| Sep 30, 2021 | -0.04 |
| Jun 30, 2021 | 0.07 |
| Dec 31, 2020 | -1.08 |
| Sep 30, 2020 | -0.21 |
| Jun 30, 2020 | 0.08 |
| Mar 31, 2020 | 0.08 |
| Dec 31, 2019 | 0.04 |
| Sep 30, 2019 | 0.05 |